These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level. Xiao M, Oppenlander BK, Dooley DC. Exp Hematol; 2001 Sep 15; 29(9):1098-108. PubMed ID: 11532351 [Abstract] [Full Text] [Related]
3. Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Park JR, Bernstein ID, Hockenbery DM. Blood; 1995 Aug 01; 86(3):868-76. PubMed ID: 7542499 [Abstract] [Full Text] [Related]
4. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells. Xiao M, Oppenlander BK, Plunkett JM, Dooley DC. Exp Hematol; 1999 May 01; 27(5):916-27. PubMed ID: 10340408 [Abstract] [Full Text] [Related]
6. Flt3 ligand enhances the yield of primitive cells after Ex vivo cultivation of CD34+ CD38dim cells and CD34+ CD38dim CD33dim HLA-DR+ cells. Dooley DC, Xiao M, Oppenlander BK, Plunkett JM, Lyman SD. Blood; 1997 Nov 15; 90(10):3903-13. PubMed ID: 9354657 [Abstract] [Full Text] [Related]
8. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence. Harvey K, Higgins N, Akard L, Chang Q, Jansen J, Thompson J, Dugan M, Rizzo MT, English D. J Hematother; 1997 Jun 15; 6(3):243-52. PubMed ID: 9234179 [Abstract] [Full Text] [Related]
9. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. Sakabe H, Ohmizono Y, Tanimukai S, Kimura T, Mori KJ, Abe T, Sonoda Y. Stem Cells; 1997 Jun 15; 15(1):73-81. PubMed ID: 9007225 [Abstract] [Full Text] [Related]
10. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Roy V, Miller JS, Verfaillie CM. Exp Hematol; 1997 May 15; 25(5):387-94. PubMed ID: 9168060 [Abstract] [Full Text] [Related]
11. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells. Liu H, Verfaillie CM. Exp Hematol; 2002 Jun 15; 30(6):582-9. PubMed ID: 12063025 [Abstract] [Full Text] [Related]
13. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Prosper F, Stroncek D, Verfaillie CM. Blood; 1996 Sep 15; 88(6):2033-42. PubMed ID: 8822922 [Abstract] [Full Text] [Related]
14. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues. Huang S, Chen Z, Yu JF, Young D, Bashey A, Ho AD, Law P. Stem Cells; 1999 Sep 15; 17(5):265-72. PubMed ID: 10527461 [Abstract] [Full Text] [Related]
15. IL-3 increases production of B lymphoid progenitors from human CD34+CD38- cells. Crooks GM, Hao QL, Petersen D, Barsky LW, Bockstoce D. J Immunol; 2000 Sep 01; 165(5):2382-9. PubMed ID: 10946261 [Abstract] [Full Text] [Related]
16. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development. Waller EK, Huang S, Terstappen L. Blood; 1995 Jul 15; 86(2):710-8. PubMed ID: 7541673 [Abstract] [Full Text] [Related]
17. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Dorrell C, Gan OI, Pereira DS, Hawley RG, Dick JE. Blood; 2000 Jan 01; 95(1):102-10. PubMed ID: 10607692 [Abstract] [Full Text] [Related]
18. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38- hematopoietic stem cells. Huang S, Terstappen LW. Blood; 1994 Mar 15; 83(6):1515-26. PubMed ID: 7510144 [Abstract] [Full Text] [Related]
19. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Haylock DN, Horsfall MJ, Dowse TL, Ramshaw HS, Niutta S, Protopsaltis S, Peng L, Burrell C, Rappold I, Buhring HJ, Simmons PJ. Blood; 1997 Sep 15; 90(6):2260-72. PubMed ID: 9310477 [Abstract] [Full Text] [Related]
20. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Borge OJ, Ramsfjell V, Cui L, Jacobsen SE. Blood; 1997 Sep 15; 90(6):2282-92. PubMed ID: 9310479 [Abstract] [Full Text] [Related] Page: [Next] [New Search]